InjectionClinical Overview
Piroxicam Injection (20mg, 40mg with Benzyl Alcohol) is a parenteral oxicam-class NSAID on the WHO Model List framework. It inhibits COX-1 and COX-2 and suppresses neutrophil activation. Indicated for acute relief of severe exacerbations of osteoarthritis, rheumatoid arthritis, and acute musculoskeletal pain when oral dosing is unfeasible.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Administer by deep intramuscular (IM) injection only into the upper outer quadrant of the buttock: 20 mg once daily (maximum 40 mg daily for 1-2 days only). Switch to oral therapy promptly.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Injection site pain, induration, dyspepsia, nausea, dizziness. Rare/Severe: Severe gastrointestinal ulceration/bleeding, Nicolau syndrome, and nephrotoxicity.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
High gastrointestinal toxicity profile. Strictly for deep IM injection; avoid vascular injection. Contains benzyl alcohol; contraindicated in neonates and infants. Maximum parenteral duration: 2 to 3 days.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or analgesic treatment guidance. Always consult a registered physician or orthopedic specialist before taking pain relievers, anti-inflammatory medications, or anti-arthritic therapies.
Piroxicam Capsules 20 mg
Piroxicam Capsules / Dispersible Tablets (10mg, 20mg) is an oral oxicam-class non-steroidal anti-inflammatory drug on the WHO Model List of Essential Medicines. Characterized by a very long elimination half-life (~50 hours), allowing once-daily dosing. Dispersible tablets disintegrate rapidly in water for easy administration. Indicated for symptomatic relief of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
Piroxicam Dispersible Tablets 10 mg
Piroxicam Capsules / Dispersible Tablets (10mg, 20mg) is an oral oxicam-class non-steroidal anti-inflammatory drug on the WHO Model List of Essential Medicines. Characterized by a very long elimination half-life (~50 hours), allowing once-daily dosing. Dispersible tablets disintegrate rapidly in water for easy administration. Indicated for symptomatic relief of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
Piroxicam Dispersible Tablets 20 mg
Piroxicam Capsules / Dispersible Tablets (10mg, 20mg) is an oral oxicam-class non-steroidal anti-inflammatory drug on the WHO Model List of Essential Medicines. Characterized by a very long elimination half-life (~50 hours), allowing once-daily dosing. Dispersible tablets disintegrate rapidly in water for easy administration. Indicated for symptomatic relief of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
Piroxicam with bezyl alcohol Injection 20 mg
Piroxicam Injection (20mg, 40mg with Benzyl Alcohol) is a parenteral oxicam-class NSAID on the WHO Model List framework. It inhibits COX-1 and COX-2 and suppresses neutrophil activation. Indicated for acute relief of severe exacerbations of osteoarthritis, rheumatoid arthritis, and acute musculoskeletal pain when oral dosing is unfeasible.